Increased delivery of a nucleic acid construct in vivo by the poly-l-glutamate (plg) system
CA 2485976 A1 · Owner: Carpenter, Robert H. · Inventors: Hill, Leigh Anne; Draghia-Akli, Ruxandra; Hebel, Henry
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Plasmid DNA delivered by injection / electroporation to the skeletal muscle can be expressed, and physiologic levels of transgene could be achieved into the circulation. Nevertheless, stabilization of naked DNA may be required and necessary in some cases, as prolonged storage at different temperatures before usage, injection into a large number of animals etc. It is imperative that , the associated compound should not be toxic to the cells (e.g. muscle cells) or cause breakage of plasmid DNA. It would be preferable for the coated DNA to have a similar or increased uptake into the target cells. Low molecular weight poly~L-glutamate compounds have all the desired properties. It was …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 23, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.